[Oral streptococci: implications in infectious pathology].
Băncescu
Gabriela
G
U.M.F. Carol Davila, I.N.C.D.M.I. Cantacuzino.
Băncescu
A
A
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001922:Brain Abscess / Q000188:drug therapy / Q000382:microbiology / Q000517:prevention & control; D003731:Dental Caries / Q000382:microbiology / Q000517:prevention & control / Q000628:therapy; D004697:Endocarditis, Bacterial / Q000188:drug therapy / Q000382:microbiology / Q000517:prevention & control; D006801:Humans; D010482:Periapical Abscess / Q000188:drug therapy / Q000382:microbiology / Q000517:prevention & control; D012307:Risk Factors; D018805:Sepsis / Q000188:drug therapy / Q000382:microbiology / Q000517:prevention & control; D013290:Streptococcal Infections / Q000188:drug therapy / Q000382:microbiology* / Q000517:prevention & control; D019533:Streptococcus oralis / Q000472:pathogenicity*; D016896:Treatment Outcome; D034363:Viridans Streptococci / Q000472:pathogenicity
D000900:Anti-Bacterial Agents